Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey
Still unmet problems with low molecular weight heparin prophylaxis of…
Ler MaisIntravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia
Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of…
Ler MaisDiscrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock
Discrepancy between parallel anti-Xa and activated partial thromboplastin time is…
Ler MaisHow to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of Anticoagulation
How to deal with interference on heparin anti-Xa activity caused…
Ler MaisEfficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: An observational study
Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy:…
Ler MaisIncidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis
Incidence of heparin resistance and heparin failure in patients receiving…
Ler Mais